These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20936913)

  • 21. Values of radiological examinations for the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases.
    Huang L; He H; Ding Y; Jin J; Zhan Q
    Clin Respir J; 2018 Feb; 12(2):499-509. PubMed ID: 27614086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
    Chun JY; Jeong SJ; Kim S; Choi S; Lee JH; Chung HS; Park S; Lee H; Kim HY; Hwangbo B; Choi YJ
    J Infect; 2024 Jun; 88(6):106159. PubMed ID: 38641139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
    Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
    Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
    Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
    Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons.
    Huang L; Zhang Y; Hua L; Zhan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1899-1907. PubMed ID: 33837879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.
    Trof RJ; Beishuizen A; Debets-Ossenkopp YJ; Girbes AR; Groeneveld AB
    Intensive Care Med; 2007 Oct; 33(10):1694-703. PubMed ID: 17646966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.
    Kimura SI; Odawara J; Aoki T; Yamakura M; Takeuchi M; Matsue K
    Int J Hematol; 2009 Nov; 90(4):463-470. PubMed ID: 19838867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis].
    Zhang XY; Zhao SY; Jiang ZF
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):83-6. PubMed ID: 19573449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
    Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
    BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation.
    Qiu KY; Liao XY; Huang K; Xu HG; Li Y; Fang JP; Zhou DH
    Clin Transplant; 2019 Aug; 33(8):e13641. PubMed ID: 31211850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
    Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
    J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive pulmonary aspergillosis infection in severely ill COPD patients in pulmonary ward and ICU.
    Ahmed J; Singh G; Mohan A; Agarwal R; Sachdev J; Khullar S; Bhusan Xess A; Mathur P; Das BK; Xess I
    Indian J Med Microbiol; 2022; 40(2):223-227. PubMed ID: 35292163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
    Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
    Russo A; Giuliano S; Vena A; Lucidi C; Falcone M; Raponi G; Merli M; Venditti M
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):83-6. PubMed ID: 24962954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.